Market Assessment application: market assessment of a rapid, reagent-free technology for identification of antibiotic-resistant bacteria by ATR-FTIR spectroscvopy

市场评估应用：通过 ATR-FTIR 光谱法识别抗生素耐药细菌的快速、免试剂技术的市场评估

• 批准号: 491321-2015
• 负责人: Ismail, Ashraf
• 金额: $ 0.66万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=586834
• 关键词: Market; Assessment; application; market; assessment

The objective of this NSERC-I2I market assessment application is to investigate the market potential of MIR Direct, a new and rapid technology developed at McGill University for bacteria identification in hospital clinical microbiology laboratories. MIR Direct employs "whole-organism fingerprinting" by attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy to identify bacterial species. Furthermore, this technology has the capability to discriminate between antibiotic-resistant and antibiotic-susceptible strains of the same bacterial species, which is critically important for the timely diagnosis of infections caused by antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), and the appropriate use of antibiotics. Advantages of the MIR Direct technology include: (i) minimal sample preparation, (ii) reagent-free analysis, (iii) simple (one-step), universally applicable analysis protocol, (iv) fast turnaround time (1-2 min),and (v) low cost per test. Accordingly, a market assessment study will be undertaken to guide the McGill technology transfer office in determining the commercialization strategy for this promising new bacteria identification technology.

NSERC-I2I 市场评估应用程序的目的是调查 MIR Direct 的市场潜力，MIR Direct 是麦吉尔大学开发的一项用于医院临床微生物实验室细菌鉴定的新型快速技术。 MIR Direct 采用通过衰减全反射傅立叶变换红外 (ATR-FTIR) 光谱的“整体生物体指纹识别”来识别细菌种类。此外，该技术能够区分同一菌种的抗生素耐药菌株和抗生素敏感菌株，这对于及时诊断耐甲氧西林金黄色葡萄球菌（MRSA）等抗生素耐药细菌引起的感染至关重要。 ）和耐万古霉素肠球菌（VRE），并适当使用抗生素。 MIR Direct 技术的优点包括：(i) 最少的样品制备，(ii) 免试剂分析，(iii) 简单（一步）、普遍适用的分析方案，(iv) 快速周转时间（1-2 分钟） ，以及 (v) 每次测试的成本低。因此，将进行市场评估研究，以指导麦吉尔技术转让办公室确定这种有前景的新型细菌识别技术的商业化策略。